<SEC-DOCUMENT>0001193125-20-054118.txt : 20200228
<SEC-HEADER>0001193125-20-054118.hdr.sgml : 20200228
<ACCEPTANCE-DATETIME>20200228071615
ACCESSION NUMBER:		0001193125-20-054118
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200228
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200228
DATE AS OF CHANGE:		20200228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		20665625

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d871994d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgmo="http://www.sangamo.com/20200228" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-02-28_to_2020-02-28">SANGAMO THERAPEUTICS, INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-02-28_to_2020-02-28">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-02-28_to_2020-02-28">0001001233</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="sgmo-20200228.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-02-28_to_2020-02-28"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-02-28</xbrli:startDate> <xbrli:endDate>2020-02-28</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-02-28_to_2020-02-28">8-K</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section 13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt:datemonthdayyearen">February 28, 2020</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:12pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">SANGAMO THERAPEUTICS, INC.</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-02-28_to_2020-02-28">000-30171</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-02-28_to_2020-02-28">68-0359556</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">ID Number)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"> <ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-02-28_to_2020-02-28">7000 Marina Blvd</ix:nonNumeric>., <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-02-28_to_2020-02-28">Brisbane</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-02-28_to_2020-02-28">94005</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive offices) (Zip Code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-02-28_to_2020-02-28">(510)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-02-28_to_2020-02-28">970-6000</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Registrant&#8217;s telephone number, including area code)&#160;</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Not Applicable</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Former Name or Former Address, if Changed Since Last Report)&#160;</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section 12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-02-28_to_2020-02-28">Common Stock, $0.01 par value per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-02-28_to_2020-02-28">SGMO</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-02-28_to_2020-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;2.02 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Results of Operations and Financial Condition.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On February&#160;28, 2020, Sangamo Therapeutics, Inc. (&#8220;Sangamo&#8221;) issued a press release announcing its financial results for the quarter and year ended December&#160;31, 2019 (the &#8220;Press Release&#8221;). </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">A copy of the Press Release is furnished hereto as Exhibit 99.1 and is incorporated by reference herein. The information contained in this Item 2.02 and in the Press Release furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the Press Release furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> shall not be incorporated by reference into any filing with the SEC made by Sangamo whether made before or after the date hereof, regardless of any general incorporation language in such filing. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">(d) <span style="font-style:Italic">Exhibits</span>. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:5%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;text-align:center;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Exhibit&#32;<br />No. </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;display:inline-block;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:left;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Description </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">99.1</p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d871994dex991.htm">Press Release regarding financial results dated February&#160;28, 2020</a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104</p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (embedded within the Inline XBRL document) </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:45%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:4%;"></td>
<td style="width:1%;"></td>
<td style="width:44%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td colspan="3" style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SANGAMO THERAPEUTICS, INC. </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Dated: February&#160;28, 2020 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ <span style="font-variant:small-caps">Alexander D. Macrae</span></p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Name: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Alexander D. Macrae, M.B., Ch.B., Ph.D. </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Title: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">President and Chief Executive Officer </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d871994dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g871994g99t21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANGAMO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Conference Call and Webcast Scheduled for 8 a.m. Eastern Time </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brisbane, California</B>, <B>February</B><B></B><B>&nbsp;28, 2020 </B>&#150; Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today
reported fourth quarter and full year 2019 financial results and recent business highlights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This quarter marked an important milestone for
Sangamo, as we transitioned to a Phase III company following the transfer of the IND for <FONT STYLE="white-space:nowrap">SB-525</FONT> hemophilia A gene therapy to our partner Pfizer, who plan to commence the registrational study this year. This is
a significant step in our mission to bring our genomic medicines to patients,&#148; said Sandy Macrae, CEO of Sangamo. &#147;Additionally this year, we look forward to progressing our wholly owned assets,
<FONT STYLE="white-space:nowrap">ST-920</FONT> gene therapy for Fabry disease and TX200 <FONT STYLE="white-space:nowrap">CAR-Treg</FONT> cell therapy, in the clinic, and will work closely with our collaborator, Kite, as they advance <FONT
STYLE="white-space:nowrap">KITE-037,</FONT> an anti-CD19 allogeneic <FONT STYLE="white-space:nowrap">CAR-T</FONT> therapy into a Phase 1/2 clinical trial. We will also continue to advance new IND targets in highly prevalent diseases, as exemplified
by the newly announced Biogen collaboration, and will continue to look for additional synergistic partnership opportunities to advance our mission to bring innovative genomic medicines to patients and to create value for our shareholders.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Highlights </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Yesterday, announced global collaboration agreement with Biogen to develop and commercialize gene regulation
therapies for Alzheimer&#146;s, Parkinson&#146;s, neuromuscular and other neurodegenerative diseases. Under the terms of the collaboration, Biogen has exclusive global rights to <FONT STYLE="white-space:nowrap">ST-501</FONT> for tauopathies
including Alzheimer&#146;s disease, <FONT STYLE="white-space:nowrap">ST-502</FONT> for synucleinopathies including Parkinson&#146;s disease, and a third undisclosed neuromuscular disease target. In addition, Biogen has exclusive rights to nominate
up to nine additional undisclosed targets over a target selection period of five years. Closing of the transaction is contingent on completion of review under antitrust laws, including the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the
United States (HSR). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Completed the transfer of the investigational new drug application (IND) for
<FONT STYLE="white-space:nowrap">SB-525</FONT> gene therapy in hemophilia A to development partner Pfizer, triggering a $25&nbsp;million milestone payment. Pfizer is currently enrolling patients in a <FONT STYLE="white-space:nowrap">6-month</FONT>
Phase 3 <FONT STYLE="white-space:nowrap">lead-in</FONT> study, which serves as the foundation of the Phase 3 registrational study. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Presented updated <FONT STYLE="white-space:nowrap">follow-up</FONT> of the Phase 1/2 Alta Study assessing <FONT
STYLE="white-space:nowrap">SB-525</FONT> in adult patients with severe hemophilia A in partnership with Pfizer at the 61<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> American Society of Hematology (ASH) annual meeting in December 2019. The
data showed that <FONT STYLE="white-space:nowrap">SB-525</FONT> was generally well tolerated and demonstrated sustained increased Factor VIII levels following treatment with <FONT STYLE="white-space:nowrap">SB-525</FONT> through to 44 weeks, the
extent of <FONT STYLE="white-space:nowrap">follow-up</FONT> for the longest treated patient in the 3e13 vg/kg dose cohort. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Received Orphan Drug Designation from the European Medicines Agency for
<FONT STYLE="white-space:nowrap">ST-920,</FONT> an investigational gene therapy candidate for Fabry disease. Six US sites are currently active and screening subjects for the Phase 1/2 STAAR study evaluating
<FONT STYLE="white-space:nowrap">ST-920,</FONT> which Sangamo is enrolling in 2020. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Presented preliminary data from the Phase 1/2 THALES Study assessing
<FONT STYLE="white-space:nowrap">ST-400,</FONT> investigational <I>ex vivo</I> gene-edited cell therapy in patients with transfusion-dependent beta thalassemia in partnership with Sanofi at ASH. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achieved $7.5&nbsp;million milestone from Sanofi for the first patient dosed in their Phase 1/2 <FONT
STYLE="white-space:nowrap">PRECIZN-1</FONT> trial evaluating BIVV003, investigational <I>ex vivo</I> gene-edited cell therapy for the treatment of sickle cell disease. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Received clinical trial application authorization in the United Kingdom for the Phase 1/2 <B>ST</B>EADFAST
clinical study evaluating the <FONT STYLE="white-space:nowrap">CAR-Treg</FONT> cell therapy TX200 for kidney transplantation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Hosted R&amp;D Day in New York where Sangamo executives and scientists provided updates across the Company&#146;s
clinical and preclinical pipeline, as well as an overview of manufacturing capabilities to support clinical and commercial supply. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Established new Scientific Advisory Board comprising industry and academic international thought leaders who will
advise Sangamo on its current and future clinical programs and research and development strategy. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fourth Quarter 2019 Financial
Results </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the fourth quarter ended December&nbsp;31, 2019, Sangamo reported consolidated net income attributable to Sangamo of $4.6&nbsp;million, or
$0.04 per share, compared to a net loss attributable to Sangamo of $18.7&nbsp;million, or $0.18 per share, for the same period in 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenues for the
fourth quarter ended December&nbsp;31, 2019 were $54.9&nbsp;million, compared to $26.8&nbsp;million for the same period in 2018. The increase in revenue was primarily attributable to a $25.0&nbsp;million milestone achieved for the completion of the
IND transfer for <FONT STYLE="white-space:nowrap">SB-525</FONT> to Pfizer for hemophilia A, and a $7.5&nbsp;million milestone achieved for dosing the first subject in the BIVV003 sickle cell disease Phase 1/2 clinical trial partnered with Sanofi.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total operating expenses were $53.4&nbsp;million for the fourth quarter ended December&nbsp;31, 2019, compared to $47.6&nbsp;million for the same period
in 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses were $38.3&nbsp;million for the fourth quarter of 2019, compared to $33.3&nbsp;million for the same period in
2018. General and administrative expenses were $15.1&nbsp;million for the fourth quarter of 2019, compared to $14.4&nbsp;million for the same period in 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Full Year 2019 Results </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended
December&nbsp;31, 2019, the consolidated net loss attributable to Sangamo was $95.2&nbsp;million, or $0.85 per share, compared to a net loss attributable to Sangamo of $68.3&nbsp;million, or $0.70 per share, for the year ended December&nbsp;31,
2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenues were $102.4&nbsp;million in 2019, compared to $84.5&nbsp;million in 2018. The increase in revenues was primarily attributable to
milestones achieved with Sanofi and Pfizer as well as higher revenues related to our collaboration agreement with Kite, a Gilead Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On a GAAP
basis, total operating expenses were $207.6&nbsp;million in 2019, compared to $161.6&nbsp;million in 2018. Stock-based compensation expense included in total operating expenses in 2019 was $19.3&nbsp;million, compared to $14.7&nbsp;million in 2018.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> total operating expenses excluding the above stock-based
compensation expense, were $188.3&nbsp;million and $146.9&nbsp;million in 2019 and 2018, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The increase in total operating expenses was
primarily related to the Company&#146;s overall headcount growth and facilities expansion to support the advancement of Sangamo&#146;s therapeutic pipeline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses were $145.9&nbsp;million in 2019, compared to $114.9&nbsp;million in 2018. General and administrative expenses were
$61.7&nbsp;million in 2019, compared to $46.7&nbsp;million in 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the Company had cash, cash equivalents, marketable
securities and interest receivable of $385.0&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Guidance for 2020 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On a GAAP basis, Sangamo expects total operating expenses to be in the range of $270 to $285&nbsp;million in 2020, which includes <FONT
STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation expense of approximately $25&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> total operating expenses, excluding expected <FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based
compensation expense of approximately $26&nbsp;million, are expected to be in the range of $245 to $260&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sangamo will host a conference call today, February&nbsp;28, 2020, at 8:00 a.m. Eastern Time, which will be open to the public. The call will also be webcast
live and can be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under <U>Events and Presentations</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
conference call <FONT STYLE="white-space:nowrap">dial-in</FONT> numbers are (877) <FONT STYLE="white-space:nowrap">377-7553</FONT> for domestic callers and (678) <FONT STYLE="white-space:nowrap">894-3968</FONT> for international callers. The
conference ID number for the call is 4609858. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under <U>Events and Presentations</U>. A conference call replay will be
available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) <FONT STYLE="white-space:nowrap">859-2056</FONT> and (404) <FONT STYLE="white-space:nowrap">537-3406,</FONT>
respectively. The conference ID number for the replay is 4609858. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Sangamo Therapeutics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients&#146; lives using gene
therapy, <I>ex vivo</I> gene-edited cell therapy, and <I>in vivo</I> genome editing and genome regulation. For more information about Sangamo, visit <U>www.sangamo.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forward-Looking Statements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release
contains forward-looking statements regarding Sangamo&#146;s current expectations. These forward-looking statements include, without limitation, statements regarding the closing of Sangamo&#146;s recently-announced global collaboration agreement
with Biogen, Pfizer&#146;s plans to commence a registrational study for <FONT STYLE="white-space:nowrap">SB-525</FONT> this year, Sangamo&#146;s expectations of progressing its wholly-owned assets in the clinic, the expected advancement of <FONT
STYLE="white-space:nowrap">KITE-037</FONT> into a Phase 1/2 clinical trial, Sangamo&#146;s expectation of advancing new IND targets, potential additional synergistic partnership opportunities for Sangamo to advance its mission to bring
</I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
innovative genomic medicines to patients and to create value for its stockholders, Sangamo&#146;s 2020 financial guidance related to GAAP and <FONT STYLE="white-space:nowrap">non-GAAP</FONT>
total operating expenses, and other statements that are not historical fact. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could
cause actual results to differ include, but are not limited to, the dependence on the success of clinical trials, the lengthy and uncertain regulatory approval process, risks and uncertainties related to the initiation, enrollment and completion of
clinical trials, whether the final results from a study will validate and support interim safety and efficacy data, Sangamo&#146;s reliance on partners and other third-parties to meet their clinical and manufacturing obligations, and the ability to
maintain strategic partnerships and collaborations. Further, there can be no assurance that (i)&nbsp;Sangamo&#146;s global collaboration agreement with Biogen will become effective and that the transaction will otherwise close, including as a result
of the failure by the parties to clear HSR review or otherwise satisfy closing conditions or (ii)&nbsp;the necessary regulatory approvals will be obtained or that Sangamo and its partners will be able to develop commercially viable product
candidates. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in Sangamo&#146;s operations and business environments. These risks and uncertainties are described more fully in
Sangamo&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2019 as filed with the Securities and Exchange Commission and Sangamo&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> that it intends to file shortly. Forward-looking statements contained in this announcement are made as of this date, and Sangamo undertakes no duty to update such information except as required under applicable
law. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>To supplement Sangamo&#146;s financial results and guidance presented in accordance with GAAP, Sangamo presents
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> total operating expenses, which exclude stock-based compensation expense from GAAP total operating expenses. Sangamo believes that this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial
measure, when considered together with its financial information prepared in accordance with GAAP, can enhance investors&#146; and analysts&#146; ability to meaningfully compare Sangamo&#146;s results from period to period and to its forward-looking
guidance, and to identify operating trends in Sangamo&#146;s business. Sangamo has excluded stock-based compensation expense because it is a <FONT STYLE="white-space:nowrap">non-cash</FONT> expense that may vary significantly from period to period
as a result of changes not directly or immediately related to the operational performance for the periods presented. This <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure is in addition to, not a substitute for, or superior to,
measures of financial performance prepared in accordance with GAAP. Sangamo encourages investors to carefully consider its results under GAAP, as well as its supplemental <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial information, to
more fully understand Sangamo&#146;s business. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Investor Relations &#150; Global</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">McDavid Stilwell </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">510-970-6000,</FONT></FONT> x219 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>mstilwell@sangamo.com</U> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Media Inquiries &#150; Global</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aron Feingold </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">510-970-6000,</FONT></FONT> x421 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>afeingold@sangamo.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Investor Relations and Media Inquiries &#150; European Union&nbsp;&amp; United Kingdom</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Caroline Courme </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">33 4 97 21 27 27 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>ccourme@sangamo.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-more- </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SELECTED CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(unaudited; in thousands, except per share data) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Statement of
Operations Data: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Three months ended<br>December 31,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Year ended<br>December 31,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">102,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">84,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,736</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">207,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income (loss) from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,772</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105,180</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,761</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss) attributable to Sangamo Therapeutics, Inc. stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,219</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(95,419</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,889</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss) attributable to Sangamo Therapeutics, Inc. stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(18,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(95,186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(68,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net income (loss) per common share attributable to Sangamo Therapeutics Inc.
stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing basic net income (loss) per common share attributable to Sangamo
Therapeutics, Inc. stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,903</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing diluted net income (loss) per common share attributable to Sangamo
Therapeutics, Inc. stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,&nbsp;2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,&nbsp;2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, marketable securities and interest receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;384,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;400,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">637,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">590,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sgmo-20200228.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-1 Build:20200220.9 -->
<!-- Creation date: 2/28/2020 1:06:12 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:sgmo="http://www.sangamo.com/20200228"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.sangamo.com/20200228"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20200228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20200228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>sgmo-20200228_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-1 Build:20200220.9 -->
<!-- Creation date: 2/28/2020 1:06:12 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>sgmo-20200228_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-1 Build:20200220.9 -->
<!-- Creation date: 2/28/2020 1:06:12 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sgmo-20200228.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g871994g99t21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g871994g99t21.jpg
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M P,# P,# P,# P,# P,# P,# P,# P/_P  1" !; 38# 1$  A$! Q$!_\0
MV@   0(' 0$               D* 0(%!@<("P,$ 0 !! ,! 0
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M$-W/F3<S3V/>$-3QG7W:[$<ZY=AJM954%!2%[4:K%R-ODH50X!T0E)1BQ*J
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MU'_AXQMSUI_-$$]F,?440,4!#P$ 'P$/V!ZZ7*6$*Q'ULX\3K%*H!1W$=AZ
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MJ0KJ*4>W0T\LS1/L4%'S!BY._9#W; (.$TQ 0V\0UPU9;[I0C35TSK:PK N
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M4V%JW'4REYBG7=/R+2J\P:QM9A,B),5IJ/L\0P9I(MXU*X1[=T5TW3*5+XU
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MO5^]QYI,U;9 )C[1T)*)N4&X".Y6X$*.XAN-S]CWI_<.V:>ZO_K4_*4."RG
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M99X[2CQS+-:+,ME*M/O$D4'5DI$XS2EZG..D4 \A-ZXBG)4G )B!/B45.TI
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M5AAQVCJ&WZ=2D.-+"@H'$D<3WYQ86J9#]*XTN2D%)D)2P^Z4<M#EMBB.X_\
M)SD/A:*5%:&Q7EJ\T^".8_>JI#1DRNO"HK" ;"LVC5$DC" ]IO+#H&KV6&O3
M6[?8NKS856OL)(5/ZOPS$N\8]D5+O;:F[E44I0G2ET3Q&4Y1T(?21X[5/CKP
M$X\PM=B&C:=R%C^OY7R',D121DK-<<@1C>P.9"3<ID*JX/'1[U!@W[A'R6C9
M,A? 1U3+=M:_=K[4/52E.)2XH)QED9&+,[9MZ+=9&&FFT^:I )Q'$8&?<81_
M^9TX^T]QBC _)AK$LF5^A\AGQ).RC=)%)[8*I9825G81M(N #S'8UR8@3F:]
MXCY)'BQ0]T0U+'1&ZU/S-197"I5"EDNA!. (4$GTS&7:>,<#U8H&&J=BX-('
MG*7H\98>P^J-=?EA<DN*[=^9%-D7BB53)C2C96>IB/\ >[-W6)6<B)!Z0@ /
M:HXBY(H*#XB" :WNM=M0NLH*MM(14OR;D,1+("?890UTNN#J*.M2O]6:25'L
M4)S ]>,-U>3.<[!R/Y 9GSU;G2JLGDJ_V2T%*LJ=9*-@Q=BA7HAJ8Y0.1E!U
MULV;I%V#M32U,UIL]-8+=26Y*1H0QP/VI3,Y>,11=+D_<ZARLJ1J\QXXSFH
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MKU5 <_$P%LK$GV)%,[3(0@NDTCE<1SPADS_=)O8NP[@MV]+,VXXO\RI)#C8
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M)82I-92J^+,3X'OAW1QN^9BX_25,AV7*+&.1J-D9DP:H6"Q8X@FEPHD^_2(
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MT]B21&4C'+")@)=G(&C%P/Y!R.$_/3[>X"&W#4]V3K';+5MEJW+IW5U;+24
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M(@W;Y8GB#+R2CVD9LY T5DHL=4L0N\I=Q;-BG,(E1:NY:N-Y;M1 =@%5=;<
MZ[CUU)C?6[<B:7Y5ZFI*@R&*M:9R_$6F7@8CNKZ3V5XE:JA]"#P2 2.Z85[(
M^VB?+'\-H202>7O,'(#(;5(Q3*PY9.GTQ@Z*41-Y:RT'632I"F, ;^6Y3$0#
MQZ]-*KZQ;DJ$>73,T],J7V-2C_:6J'Z/I;8F0 I^J6GM*1[$"%P.-_%# /$J
MCIXYX^XR@,;U;S_BWR<65T[EIQ\ & S^PS\HY>S4V\.8PF 7"ZA""8WEE3 =
MM1G<+K77ETNUKKCCNHDE2B9$F9D,AX1(5';:.W(2BE2D:4A,Y"9 &$S*9C8H
M$R"4Q0#8!Z=.FW0 Z;;;= UJ!.D2$;8*58RQ$6W%5*!@'U@D82%8QS^URJ<W
M9GK1%)%S.RR48SATY*15*)3KNTXJ.0;E,([]B1"] #?69F'%+6J6LDZ1(3,Y
M#D)Y#NB/ZH5\MG6NB<2S+:G,(A6G$^#=$9)6 :/5I5I$'<' QC,D)1PHN0OL
M4.(Z(-:].B9T Y3,O1E%/AZ#5*_!/:Q!5R*C*])/)U[)0S1L5%@^=V9V\D+"
MY<($.!3K3+Z075<#U\PZH[Z<!EQASYJH\Q+S3I#R")$B>4I8D<.$8AI/$7C5
MC>RQ-QH.#L<U"U01G!H>=@H!JQE(WXIJNR<"R<IAYB8+-7*B9PW #%,/31.7
M='J5^Y[_ '"F-+5U"70>&E(])"02>V<9H9U"!CI^8M+*'CVMBL;2*CY^90;D
M!_*L( CLD(S?K'W,Z0C D%_) ?N>8;Z=8GRG./"\ZMDCS7 4()( X:LY<IG$
MRE/"+7C,-XRA6E2CHBB5R-CJ)/2MHIK)A&-F[.K6*;+)EE9>#;E*",:\>!-.
MP$R1 [0<' H!W#L8^$;*KE4+6M:RI2W/K$DDJ_&/VO&<7*%&JZ=H7NZ4%'DM
M[FOMJHO9"-D23"]=:2!Y1I$+/@+YJK%G(*G633/W%(<QA  W$!3,PE3SJVPT
MI2BR"2$DG2"<R$Y ]H$X]JY3Z]4T'K*O0T?#-)"8E;"]1CT$VR3R=G7:DC-R
MZR2>V[Z4D%CJK''[QQWUD$R.)AET!]86^M2E@2$U$X#(8G(<!PBQ,J8#P_FL
M(<N5\;U3(2=>.^4@R6J+;21(H\DFW3?JL!7 YFJCM-JF4XE^\! WV#0%'(Y1
MZE%>;C;/U!102H*,I8E,Y3!P)$S(D17<=8GQUB:M'IN-*9 4FJJ/'DDI P#%
M%I%F?OO+!XZ.U*(IF6=^43OW 2F NVC$8QIO5=95U1K:I1\TGA@?[,O5% H7
M'S"F+;',VW'.*:#2;'8?-+-S=9K$3$24DFNM\2LDJY:MDU4FZKCWS))"1,Y]
MA, B :SA&U77V^7!H4U4\IRD21))/(2!.4R!Q,S&0Y6JU^:EZ]/24*Q?3-2<
M2+RLR;ENDH]@G<M'JQ,DO&+*%$S=5[%N%$%!#[R9Q*/CK!)YQY[;JO+4T"H(
M41J$S(RRF.,N'*/*R5& N4*ZK=JAV$] OSM5'D7))%=,G*C!ZVDF)ED3B &^
M&D&:*Q/:51(/9K$S.,L./4A\RG44O\%<I_>PBVLBX@QIEZ$3KF4Z'5+_  B#
MH'S6/M<*REV[9\!3D!VS!V10[)T"9Q*)TNPPE$0$1#II143@)RA^ANEWM^OR
M'RV5B1TDB8Y$# ^,^R*[%46GP=4;T:&K$!&T]I&J0[>JL8:/:5Q.+6*<CB/+
M#I($CQ9N 5-YB8IB503")@$1'64J4G&<:Z:NL%3\XA]8K09Z\=0(Y*S$N$C%
MIXSP1A[#QYA3%^,Z/C]2><$<3!ZC7(V%5DSI=4BNUV:":RC=(PB9-'?RDS"(
ME* CI*I<)QO5EWN]UT_O6H+^@23/ASF.)[3C&7=@^@/S:3&C$=$$&B"#1!!H
M@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T01XG^^7[WA[/M]OLTK[
M!G*4(.GS!.4Y=ONP],1-[/O?7MX?E]OYM-M_5PEX??A2M6L2G+LE[X@?;V[_
M )>[_@Z::U>;C/\ L^[WPV]IEC_>]T>A?#2V_M9?6,.\!W1'Z=+&9S@B.LP0
M:((D^WN^]TW_ '.S]W2N[E"6]6,YY\9>Z)!_C!^GM'P^]^3?IK/V?&&A+YG&
M641_AAX^'MW^CV^S?1]F R\_P[8]/S:3#OHB.L0J/,WB'A^7??\ )I0RAER6
MH9>^(CX>WP]OA^7;KH&<.)G,9^J O[GL\/V>N@PHSU<?5*#V#]OM_P!C1&$9
MG/. -^X=^[P'QV_8VT<.$-IGYF.KQE+U>^#V!]OM\/V-'&%N>^/-3^#OO][^
L%X_[WIMI2>,H8J9:DY9]L>@?V;[;?D]NVDF'!/P\/Z8G#^S;28<$&B,Q_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d871994d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d871994d8k.htm">d871994d8k.htm</File>
    <File>d871994dex991.htm</File>
    <File>sgmo-20200228.xsd</File>
    <File>sgmo-20200228_lab.xml</File>
    <File>sgmo-20200228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d871994d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgmo-20200228.xsd" xlink:type="simple"/>
    <context id="duration_2020-02-28_to_2020-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2020-02-28</startDate>
            <endDate>2020-02-28</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-02-28_to_2020-02-28"
      id="Hidden_dei_EntityRegistrantName">SANGAMO THERAPEUTICS, INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-02-28_to_2020-02-28">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-02-28_to_2020-02-28"
      id="Hidden_dei_EntityCentralIndexKey">0001001233</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-02-28_to_2020-02-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-02-28_to_2020-02-28">2020-02-28</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-02-28_to_2020-02-28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-02-28_to_2020-02-28">000-30171</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-02-28_to_2020-02-28">68-0359556</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-02-28_to_2020-02-28">7000 Marina Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-02-28_to_2020-02-28">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-02-28_to_2020-02-28">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-02-28_to_2020-02-28">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-02-28_to_2020-02-28">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-02-28_to_2020-02-28">970-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-02-28_to_2020-02-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-02-28_to_2020-02-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-02-28_to_2020-02-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-02-28_to_2020-02-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-02-28_to_2020-02-28">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-02-28_to_2020-02-28">SGMO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-02-28_to_2020-02-28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-02-28_to_2020-02-28">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    "  $.EQ0'FQ"[.X    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+!3L,P#(9?!>7>.LW00%'7"X@32$A, G&+'&^+:-HH,6KW]J1E
MZX3@ 3C&_O/YL^0:@\8^TG/L T5VE*Y&WW9)8]B( W/0  D/Y$TJ<Z++S5T?
MO>'\C'L(!C_,GD!)N09/;*QA Q.P" M1-+5%C9$,]_&$M[C@PV=L9YA%H)8\
M=9R@*BL0S30Q',>VA@M@@C%%G[X+9!?B7/T3.W= G))C<DMJ&(9R6,VYO$,%
M;T^/+_.ZA>L2FPXI_TI.\S'01IPGOZ[N[K</HE%2R4*J0MUNY8VNUEI>OT^N
M/_PNPKZW;N?^L?%9L*GAUUTT7U!+ P04    "  $.EQ0F5R<(Q &  "<)P
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M7S%1]_276<]>@C"MA[_)1/TUP.K795]02P,$%     @ !#I<4 N/V ,A 0
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M"U!+ 0(4 Q0    (  0Z7% ?(\\#P    !,"   +              "  0
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (  0Z7% GZ(<.@@   +$    0
M          "  >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ !#I<
M4!YL0NSN    *P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ !#I<4)E<G",0!@  G"<  !,              ( !
MM@(  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  $.EQ0"ZJ<K9H"
M  "3"P  &               @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @ !#I<4%3'ITQ9 @  ^@4  !0              ( !
MQPL  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ !#I<4+JA.8K7
M 0  ,@8   T              ( !4@X  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  $.EQ0%FTC?T,!   \ @  #P              @ %4$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ !#I<4/_ )@B]    A0(  !H
M     ( !Q!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ !#I<4 N/V ,A 0  5P0  !,              ( !N1(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      H "@"  @  "Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6628235632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANGAMO THERAPEUTICS, INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001001233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0359556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Marina Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">970-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGMO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-20-054118-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-054118-xbrl.zip
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M^T#O'=.0%YZKFZN_19,:G"=^+/]V1/Z4T 28$L(4@8%Q+9O+;BLF;EOR@/A
MB]?BXBS\*ME+%A>'K):1#3G=^LH0, %6T&)Z-[:<(;46]8Y0,-ELBM+$C9O4
M31!X@]TSRYEQ^>=^RT44 8\0)AD,:6#Q(;(986]0ZU QVM;_)@P(=)&)M8]@
M%V[!O<-".7;XC<T"UYD&G@YC"-CBX"#B>X/A$URAG,JZY,F=#6HF7#ESIY[R
MXPDS(B<PX;9(MP#@H(:+F;M"5V!RFSBA:J&H#"I.RZ>! T9A M/,9DP;AC;0
MCB1GJPC6-GQ&*?X,,&V!;C'35D\BT8.23(P>A.RCZ)O!#0<V?,W=E9%@LO*8
MPI3G 7N&1G4%UR)VH7VTP?QE,\&,?T90&C/)\:<J5^'<(R"5'PFX3Z9S@9LQ
MUW0,7+T1/@31!"SN&=S,<<,H FM4W "00[B$,4JI8W-\9S'^&UP.?L@$10BX
M=*#S]-T X@B+/GA:C'TXZB5XBUQ?!Z7*]1SXUB'M\/KN%.#+/=<$C[1U'X<N
M-NLU"0RRF3MP+#"]O@]\\,CQ9;_W3F!EKOOP1P__0*N9&N'4".-:G@DY19U8
M$G^8]CT8:7.L\#]"+<,-QH3. $#IPCH? _AZ)P*@+>.4!=R,L"T>MT3FG5O^
M9,@"Z' \9APF4?*V5!7LA4E;2%,4F,WH'._/RQNYI@8N!/8^X#UFNV"9<8P0
M2@$9]'FS6,M-@9$3.9%L1L#7\O,W6HP:((N* SR@POC+U"=@?UQ@M\3H&#;;
M!E46!+]1#UD6E*5JGJKY&C6_A9@7<UO@?&<@5/#WLY(J,A.Y8*9D=4$*,5)K
M6SX%7X,I 8R<15"]042Y: 10X8S \B,5Y"#/ ]UWV:))@$OCP12_3JHU]3EQ
MM>))_VZ)Q#>JOWTD,*"/D66.IY(_\"7P_)/W<$>+M $>8?*"]!W=9/X<IWO)
MIA \0X [)\?M_N4[Q*D!:-R4,5_$9^0<HISID(E$%N9#P L#@RF$7<X#MZI
MV99F\0$L@$"7F)IXX"D QT*PR?-/!MA%L#[< L 7'B #:F+Z H"$B_#)(!<
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MOT.C$.G1X+)]U>DG$<]F>E0I1'J4- HGW19[)/?FO8/;AMQ&Y,  (5GQ_+^
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MB$6X2GDDX"EWK&M2;:[@%3:L>A()?K@8-"Q^,6X^X>6\OPJND%]%';5Y@MG
M*03T,!>D329QXNNCP9"@OJB4#P\/>4^>V@#,BFSV?K.E7<Q9XMD/N2O'X0O
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M;^(GW[T(><5"52LV"J^6OGI=*U:W)>]G#@5VJ:ORI,6HN5N\*D'#4Z!?;$M
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MMJ]7/\5D?8R[FWC<VZMVW>#/7U!+ P04    "  %.EQ0HK^ER&,&  !(1
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M,3DY-&0X:RYH=&U02P$"% ,4    "  %.EQ0W2>N2'X<  #<T   $0
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7;%!+!08     !0 % $ !  # .P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d871994d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d871994d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgmo-20200228_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgmo-20200228_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "sgmo-20200228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sgmo",
   "nsuri": "http://www.sangamo.com/20200228",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d871994d8k.htm",
      "contextRef": "duration_2020-02-28_to_2020-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d871994d8k.htm",
      "contextRef": "duration_2020-02-28_to_2020-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
